These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7721242)

  • 1. Is Crohn's disease caused by antibiotics?
    Demling L
    Hepatogastroenterology; 1994 Dec; 41(6):549-51. PubMed ID: 7721242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Crohn disease caused by antibiotics? A medical hypothesis based on epidemiologic data].
    Demling L
    Fortschr Med; 1994 May; 112(14):195-6. PubMed ID: 8050759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease: the case for bacteria.
    Prantera C; Scribano ML
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):244-6. PubMed ID: 10379488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of inflammatory bowel disease with antibiotics.
    Isaacs KL; Sartor RB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):335-45, x. PubMed ID: 15177542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current orientation on medical therapy of Crohn disease].
    Grassi M; Raffa S; Damiani VC; Gurgo AM; Messini F
    Clin Ter; 1995 Nov; 146(11):737-45. PubMed ID: 8720350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment.
    Guslandi M; Fanti L; Testoni PA
    Hepatogastroenterology; 2002; 49(47):1296-7. PubMed ID: 12239929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.
    Balfour Sartor R
    J Clin Gastroenterol; 2007; 41 Suppl 1():S37-43. PubMed ID: 17438417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Crohn's disease: review of the acquisitions and problems of etiopathogenesis, histogenesis and therapy].
    Coraggio F; Gallo V; Caprio N; D'Amora M
    Clin Ter; 1981 Aug; 98(3):309-25. PubMed ID: 6269794
    [No Abstract]   [Full Text] [Related]  

  • 10. A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease.
    Rahimi R; Nikfar S; Rezaie A; Abdollahi M
    Clin Ther; 2006 Dec; 28(12):1983-8. PubMed ID: 17296455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapies for Crohn's disease: focus on immunomodulators and antibiotics.
    Wilhelm SM; Taylor JD; Osiecki LL; Kale-Pradhan PB
    Ann Pharmacother; 2006 Oct; 40(10):1804-13. PubMed ID: 16985094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the medical treatment of Crohn's disease.
    Valentini G; Guidi L; Costanzo M; Ciarniello M; De Vitis I; Capristo E; Fedeli G
    Panminerva Med; 2003 Mar; 45(1):15-22. PubMed ID: 12682617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherent-invasive Escherichia coli and Crohn's disease.
    Barnich N; Darfeuille-Michaud A
    Curr Opin Gastroenterol; 2007 Jan; 23(1):16-20. PubMed ID: 17133079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.
    Prantera C; Zannoni F; Scribano ML; Berto E; Andreoli A; Kohn A; Luzi C
    Am J Gastroenterol; 1996 Feb; 91(2):328-32. PubMed ID: 8607501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild-to-moderate active luminal Crohn's disease.
    Michetti P; Juillerat P; Mottet C; Pittet V; Gonvers JJ; Vader JP; Froehlich F; Felley C
    Digestion; 2007; 76(2):92-8. PubMed ID: 18239399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow up of Crohn's disease under therapy with hydro-MRI].
    Ganten M; Encke J; Flosdorff P; Grüber-Hoffmann B; Erb G; Hansmann J
    Radiologe; 2003 Jan; 43(1):26-33. PubMed ID: 12552372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New developments in Crohn's disease: solution of doctrinal mysteries and reinstatement as a surgically treatable disease. 1. The process is not a form of enteritis but lymphedema contaminated by intestinal contents].
    Tonelli P
    Chir Ital; 2000; 52(2):109-21. PubMed ID: 10832536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestinal flora and Crohn's disease].
    Desreumaux P; Colombel JF
    Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.